This inventor holds 7 USPTO granted patents. Top assignees: The Brigham and Women's Hospital, Inc., Beth Israel Hospital Assn., The Beth Israel Hospital Association. Active years: 1985-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1985-1998
Title: Alan C Moses: Innovator in Cell Modification and Insulin Resistance
Introduction
Alan C Moses is a notable inventor based in Waban, MA (US), recognized for his contributions to the field of cell biology and insulin resistance. He holds a total of 7 patents, showcasing his innovative approaches to modifying and diagnosing cell properties.
Latest Patents
Among his latest patents is a method for modifying, diagnosing, and screening for IGF-I sensitive cells. This method involves chronic modification of cell barrier properties by exposing a cell to a modification-effective amount of IGF-I for at least about 7 days. The effective amount ranges between about 50 µg/kg and less than about 500 µg/kg. This patent also discloses methods for chronic amelioration or reversal of insulin resistance, as well as techniques for diagnosing and screening for rhIGF-I sensitive cell barrier properties.
Career Highlights
Throughout his career, Alan C Moses has worked with prestigious institutions such as Brigham and Women's Hospital, Inc. and Beth Israel Hospital Association. His work in these organizations has significantly contributed to advancements in medical research and treatment methodologies.
Collaborations
Alan has collaborated with esteemed colleagues, including Jeffrey S Flier and Linda A Morrow, further enhancing the impact of his research and innovations.
Conclusion
Alan C Moses stands out as a significant figure in the realm of cell modification and insulin resistance, with a strong portfolio of patents and collaborations that underline his expertise and contributions to science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile